Travel patterns, work schedule, eating windows, family routines, ability to follow a daily versus weekly schedule
MMPs are available in many areas across the United States but may not be available in all areas
This is often the most appreciated improvement from patients perspective
Silva CR, Vieira DP, de Freitas AZ, Ribeiro MS
Consider methylcobalamin form for better utilization
Proven alternatives deliver comparable results with established safety: tirzepatide monotherapy produces 15-22% weight loss with FDA approval and extensive clinical data, while CagriSema (cagrilintide + semaglutide) delivers 15-25% weight loss with Phase 3 trial validation and clearer path to medical acceptance